BioStorage Technologies opens new biorepository
To be used to prepare, store and transport human biological samples
Indianapolis, US-based BioStorage Technologies, a life sciences logistics specialist, has opened a new 60,000ft2 state-of-the-art biorepository facility in Indianapolis.
The US$4.6m facility, located near the Indianapolis International Airport, will be used to prepare, store and transport human biological samples.
‘This new facility provides the company with the infrastructure needed to support our continued growth and expanded services,’ said Greg Swanberg, chief executive of BioStorage Technologies.
BioStorage Technologies now has the ability to offer sample preparation services, including automated liquid handling technology to ensure the accuracy and precision needed for high-throughput DNA and RNA extraction and verification.
‘The future of drug discovery is in personalised medicine and genomic-based therapies, which will require an ability to store and analyse large quantities of tissue and blood samples,’ added Swanberg.
The new biorepository facility offers a range of storage options, including automated carousel controlled-room temperature and bulk sample storage at 15–27ºC, walk-in cold sample storage at –20ºC to 5ºC, ultra-low temperature storage at –70ºC to –80ºC, and –190ºC vapour phase liquid nitrogen.